Raia DrogasilBSP:RADL3 -1.10%91 Gross Margin % is 32.12% as of Mar. 2026, which is 7% above its 10-year median of 29.95. GuruFocus rates BSP:RADL3 with a GF Score™ of 91/100 and a GF Value™ of R$29.94 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 629 Healthcare Providers & Services companies, Raia Drogasil ranks worse than 64.71% on this metric.
The historical rank and industry rank for Raia Drogasil's Gross Margin % or its related term are showing as below:
BSP:RADL3'
s Gross Margin % Range Over the Past 10 Years
Min: 29.3 Med: 29.95 Max: 31.13
Current: 30.1
During the past 13 years, the highestGross Margin % of Raia Drogasil was 31.13%. The lowest was 29.30%. And the median was 29.95%.
BSP:RADL3's Gross Margin % is ranked worse than 64.71% of 629
companies
in the Healthcare Providers & Services industry
Industry Median: 40.09
vs BSP:RADL3: 30.10
Raia Drogasil had a gross margin of 32.12% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Raia Drogasil was -0.10% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Raia Drogasil had a gross margin of 32.12% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Raia Drogasil Gross Margin % Related Terms
Raia Drogasil Gross Margin % Historical Data
* Premium members only.
The historical data trend for Raia Drogasil's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Raia Drogasil's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Raia Drogasil Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Raia Drogasil's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Raia Drogasil (BSP:RADL3) has a Gross Margin % of 32.12% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Raia Drogasil and its competitors. This is near median its historical median of 29.95. Over the past decade, Raia Drogasil's Gross Margin % has ranged from 29.30 to 31.13. According to the industry distribution chart, Raia Drogasil ranks #407 out of 629 companies in the Healthcare Providers & Services industry, placing it in the top 64.7%.
Is Raia Drogasil's Gross Margin % too high?
Raia Drogasil's current Gross Margin % of 32.12% is near median its 10-year median of 29.95. Over the past 10 years, this metric has ranged from a low of 29.30 to a high of 31.13. The Healthcare Providers & Services industry median Gross Margin % is 40.09. Raia Drogasil's value of 32.12% is 19.9% below this industry median. Based on the distribution chart, Raia Drogasil ranks #407 out of 629 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Raia Drogasil has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raia Drogasil's Gross Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Raia Drogasil ranks #407 out of 629 companies for Gross Margin %. This places Raia Drogasil in the lower half of its industry. The industry median Gross Margin % is 40.09. Raia Drogasil's value of 32.12% is 19.9% below this benchmark. Historically, Raia Drogasil's own Gross Margin % has ranged from 29.30 to 31.13 over the past decade. While the company's 10-year median is 29.95 vs. the industry median of 40.09, Raia Drogasil has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.09, based on 629 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Raia Drogasil's current Gross Margin % of 32.12% is 19.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Raia Drogasil and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Raia Drogasil's current Gross Margin % is 32.12%, which is near median its own 10-year median of 29.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raia Drogasil stock overvalued right now?
Based on GuruFocus' analysis, Raia Drogasil (BSP:RADL3) is currently considered Significantly Undervalued. The stock's GF Value™ is R$29.94, compared to a current price of R$17.16 — trading 42.7% below its estimated fair value. The current Gross Margin % is 32.12%, which is near median its 10-year median of 29.95 and 19.9% below the Healthcare Providers & Services industry median of 40.09. Raia Drogasil's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Raia Drogasil (BSP:RADL3), the current Gross Margin % is 32.12% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Raia Drogasil (BSP:RADL3) Overvalued in 2026?
Based on GuruFocus' analysis, Raia Drogasil stock appears to be undervalued.
The current stock price of R$17.16 is trading 42.7% below its estimated GF Value™ of R$29.94.
GuruFocus considers Raia Drogasil to be Significantly Undervalued.
Key valuation signals for BSP:RADL3:
Gross Margin %: 32.12% (near median its 10-year median of 29.95)
GF Value™: R$29.94 vs. price of R$17.16 (42.7% below fair value)
Industry Position: 19.9% below the Healthcare Providers & Services median (#407 of 629)
No single metric tells the full story. See the BSP:RADL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Raia Drogasil SA operates a chain of pharmacies in Brazil. The company is mainly engaged in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines. Its pharmacies mainly operate under the Drogasil and Raia brands.
91GF Score
Get the complete analysis for BSP:RADL3
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:RADL3 has been successfully added to your 
